Filing Details

Accession Number:
0001213900-17-012293
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-17 16:32:43
Reporting Period:
2017-11-15
Accepted Time:
2017-11-17 16:32:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1498382 Delmar Pharmaceuticals Inc. DMPI Pharmaceutical Preparations (2834) 990360497
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569585 K John Bell Suite 720-999 West Broadway
Vancouver A1 V5Z 1K5
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-11-15 1,871 $0.81 76,890 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-11-16 18,129 $0.81 95,019 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $0.7997 to $0.84. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $0.8086 to $0.81. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Shares are held by Onbelay Capital Inc.